With Cancer Genome Atlas Research Data, Researchers Refine Prognostic Signatures for Ovarian Cancer | GenomeWeb

NEW YORK (GenomeWeb News) – Drawing on Cancer Genome Atlas Research data, the University of Texas MD Anderson Cancer Center's Roel Verhaak and an international team of researchers expanded on subtype and survival gene expression signatures for patients with high-grade serous ovarian carcinoma.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.